The viral infectivity factor (Vif) of HIV-1 unveiled

被引:51
|
作者
Rose, KM [1 ]
Marin, M [1 ]
Kozak, SL [1 ]
Kabat, D [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA
关键词
D O I
10.1016/j.molmed.2004.04.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The viral infectivity factor (Vif) of HIV type-1 (HIV-1) is essential for efficient viral replication, yet was, until recently, enigmatic. This resulted from the complexity and cellular specificity of its function and the correspondingly complex systems that are required for its investigation. These limitations have been overcome and Vif function has been rapidly elucidated, with implications for the development of drugs to block its activity. These studies have revealed a novel component of the innate immune system, APOBEC3G, that lethally hypermutates retroviruses, including HIV-1. For HIV-1, the competition between the virus and APOBEC3G is tipped in favor of the invader by Vif, which binds to APOBEC3G and triggers its polyubiquitination and rapid degradation, thereby preventing its entry into progeny virions.
引用
收藏
页码:291 / 297
页数:7
相关论文
共 50 条
  • [1] How Vif regulates the infectivity of HIV-1
    Takaori-Kondo, A
    SEIKAGAKU, 2004, 76 (12): : 1569 - 1573
  • [2] Effects of lysine to arginine mutations in HIV-1 Vif on its expression and viral infectivity
    Khamsri, Boonruang
    Fujita, Mikako
    Kamada, Kazuya
    Piroozmand, Ahmad
    Yamashita, Tomoki
    Uchiyama, Tsuneo
    Adachi, Akio
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 18 (04) : 679 - 683
  • [3] On the Solution Conformation and Dynamics of the HIV-1 Viral Infectivity Factor
    Marcsisin, Sean R.
    Narute, Purushottam S.
    Emert-Sedlak, Lori A.
    Kloczewiak, Marek
    Smithgall, Thomas E.
    Engen, John R.
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 410 (05) : 1008 - 1022
  • [4] The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G
    Miller, James H.
    Presnyak, Vlad
    Smith, Harold C.
    RETROVIROLOGY, 2007, 4 (1)
  • [5] Synthesis and Structure-Activity Relationship Studies of HIV-1 Virion Infectivity Factor (Vif) Inhibitors that Block Viral Replication
    Ali, Akbar
    Wang, Jinhua
    Nathans, Robin S.
    Cao, Hong
    Sharova, Natalia
    Stevenson, Mario
    Rana, Tariq M.
    CHEMMEDCHEM, 2012, 7 (07) : 1217 - 1229
  • [6] The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G
    James H Miller
    Vlad Presnyak
    Harold C Smith
    Retrovirology, 4
  • [7] Antiretroviral therapy targeting HIV-1 viral infectivity factor; in silico approach
    Karau, Muriira G.
    Karau, Bundi P.
    RETROVIROLOGY, 2009, 6
  • [8] Viral Infectivity Factor: A Novel Therapeutic Strategy to Block HIV-1 Replication
    Yang, Guliang
    Xiong, Xujie
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (07) : 1047 - 1055
  • [9] Antiretroviral therapy targeting HIV-1 viral infectivity factor; in silico approach
    Muriira G Karau
    Bundi P Karau
    Retrovirology, 6
  • [10] The HIV-1 Vif protein: a paradigm for viral: cell interactions
    Pomerantz, RJ
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (10) : 2017 - 2019